LINDSEY DOCKEMEYER: Open Payments
NPI 1881154649 · HARRODSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,634 in 80 payments from 18 companies in 2025. Trend: 2023 $42 · 2024 $898 · 2025 $1,634
Food & beverage: $1,634
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $250 |
| GlaxoSmithKline, LLC. | 16 | $244 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $171 |
| AstraZeneca Pharmaceuticals LP | 2 | $169 |
| Verona Pharma, Inc. | 8 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $111 |
| Janssen Biotech, Inc. | 4 | $78 |
| QOL Medical, LLC | 3 | $76 |
| Amgen Inc. | 3 | $69 |
| Lilly USA, LLC | 4 | $68 |
Products named: REZDIFFRA, TEZSPIRE, Ohtuvayre, TRELEGY ELLIPTA, ENTYVIO, XIFAXAN, NUCALA, TREMFYA.
Industry payments across KY — which companies pay providers there.
